// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Risk of complications in conservatively managed adnexal masses initially thought to be benign at subjective impression by the ultrasound examiner

W. Froyman - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Aspirin versus placebo in pregnancies at high‐risk of preterm pre‐eclampsia: a multicentre, double‐blind, placebo‐controlled trial

D. Rolnik - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Aspirin

STRIDER UK: a randomised controlled trial of sildenafil therapy in dismal prognosis early‐onset intrauterine growth restriction

A. Sharp - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Sildenafil citrate

Endometrial biopsy prior to IVF impacts on the ultrasound appearance of the endometrium at oocyte retrieval

L. Polanski - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pelvic ultrasonography of patients awaiting uterine transplantation: the UK cohort

S. Saso - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Development of normal fetal brain structures: international standards based on ultrasound measurements from the INTERGROWTH‐21st Project

V. Donadono - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pre‐conception maternal hemodynamics is associated with subsequent development of pre‐eclampsia (PE) or intrauterine growth restriction (IUGR)

L. Foo - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arterial stiffness

N/A

Multicentre screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison to NICE guidelines and ACOG recommendations

N. O'Gorman - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pregnancy outcome in women with raised uterine artery Doppler in the second trimester

A. Kaelin Agten - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous preterm delivery

N/A

Ultrasound diagnosis of molar pregnancy

A.M. Unipan - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Recurrent hydatidiform moles

N/A

Rates of spontaneous pregnancy loss and ovulation‐implantation interval within a prospective pre‐conception cohort

L. Foo - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Spontaneous abortion

N/A

*Association of vaginal microbiota composition and outcomes in women found to have a pregnancy of unknown location (PUL) on an initial early pregnancy ultrasound scan

S. Bobdiwala - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Ectopic pregnancy

Mofezolac

IOTA benign easy descriptors and ADNEX model integrated in a ‘traffic light system’ to guide the clinical management of adnexal pathology

C. Landolfo - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prospective validation of IOTA methods in the differentiation between benign and malignant adnexal masses

W. Froyman - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ovarian masses in pregnancy

T. Eichenberger-Gautschi - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ultrasonographic differences of papillations in benign and malignant adnexal unilocular‐solid cysts with papillations and no other solid components: a retrospective multicentre study

C. Landolfo - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Ovarian cancer

N/A

*Cortical age in fetuses with heart defects using automated age‐prediction

S.M. Everwijn - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Ultrasound characteristics of endometrial cancer as defined by the International Endometrial Tumor Analysis (IETA) consensus nomenclature: a prospective multicentre study

E. Epstein - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Endometrial Cancer

N/A

Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysis

M. Gil - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

*Routine ultrasound monitoring of asymptomatic endometrial polyps offers no benefit in clinical practice

M. Wong - International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tamoxifen

Copyright © 2026. QuantiNova All rights reserved